Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Blood Gas and Electrolyte Market to Gain Impetus from High Prevalence of Cancer, Diabetes

Blog Description

Blood gas analyzers are equipment that measure pH and concentration of hydrogen ions, partial pressure of oxygen and carbon dioxide in human blood. After the blood is collected from the patient, it is injected into the analyzer. The analyzer then measures the proportion of carbon dioxide and other gases, after which the blood is automatically expelled and the sample path is cleaned for the next test.

Browse the full EME Blood Gas and Electrolyte Analyzers Market Report:http://www.mrrse.com/eme-blood-gas-electrolyte-analyzers-market

Electrolyte analyzers are used to detect metabolic disturbances and measure cardiac and renal function, by measuring electrolyte levels. Chloride, sodium, bicarbonate, and potassium are the electrolytes measured. They are used in clinics, hospitals, reference laboratories, and even point-of-care settings. Electrolyte analyzers generally use serum, urine, or plasma samples, while some might also use whole blood and cerebrospinal fluid. They are able to conduct 400 to 2400 tests per hour, depending on their efficiency.

High Incidence of Chronic Ailments and Rising Geriatric Population are among Key Market Drivers

The market for blood gas and electrolyte analyzers will gain impetus due to the following factors:

  • High incidence of chronic diseases will aid market expansion. As these tests help in diagnosis of various conditions accurately, they have been deployed widely. Obstructive pulmonary disease, diabetes, asthma, heart failure, kidney failure, drug overdose, and severe infections are some medical conditions that are diagnosed using these analyzers.
  • Growing geriatric population will bring in more consumers. The global population aged more than 65 years will rise to 16% of the total population by 2050, according to the findings of WHO. As age is a risk factor for the development of cancer and other chronic conditions that necessitate the use of blood gas and electrolyte analyzers, the market will receive significant boost over the coming years.
  • Recently, there has been a significant increase in the demand for high throughput and integrated systems. As blood gas and electrolyte analyzers are capable of integrating with EMRs/EHRs, they enable high efficiency and workflow, boosting overall growth.
  • The point-of-care diagnostic devices are exhibiting increasing demand due to growing number of patients.
  • Technological advancements in the field of blood gas and electrolyte analyzers market have also been driving demand. For example, the upgraded versions of devices deployed in this market are compact and multi-component.
  • These analyzers offer fast diagnosis, thereby ensuring faster recovery, increasing the rate of survival and avoiding complications.

The blood gas and electrolyte analyzers market has been segmented on the basis of product, modality, end-user, and geography. According to modality, the key segments are benchtop, portable, and laboratory. By product type, electrolyte analyzers, consumables, blood gas analyzers, and combination analyzers are the major categories. The end-user segment has further been segmented into clinics, hospitals, ambulatory surgical centers, and diagnostic centers.

Browse the full Press Release of EME Blood Gas and Electrolyte Analyzers Market at :http://www.mrrse.com/eme-blood-gas-electrolyte-analyzers-industry

The key players operating in the blood gas and electrolyte analyzers market are Alere Inc. (U.S.), Radiometer Medical ApS (Denmark), Instrumentation Laboratories (Werfen) (U.S.), Medica Corporation (U.S.), F.Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (U.S.), Nova Biomedical (U.S.), Siemens Healthcare (Germany), and ERBA Diagnostics Mannheim GmbH (Germany).